10 - 11 November 2021
Vaccine World Asia Congress
Singapore
Join Vaccine World Asia Congress 2021!
800+
High Profile Attendees
200+
Key Stakeholder Companies
50+
Expert Speakers
72+
Hours of Networking
The Concept
Vaccine World Asia Congress 2021 will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia Congress 2021 is the place to be!
Conference Agenda
Vaccine World Asia Congress will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia 2021 is the place to be!
Register Now!
Past Speakers
Tedros Adhanom Ghebreyesus WHO
Director-GeneralWHODr Tedros Adhanom Ghebreyesus was elected as WHO Director-General for a five-year term by WHO Member States at the Seventieth World Health Assembly in May 2017.
He is the first WHO Director-General to have been elected from multiple candidates by the World Health Assembly, and is the first person from the WHO African Region to serve as WHO’s chief technical and administrative officer.
Immediately after taking office on 1 July 2017 Dr Tedros outlined five key priorities for the Organization: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO.
Prior to his election as WHO Director-General, Dr Tedros served as Ethiopia’s Minister of Foreign Affairs from 2012–2016. In this role he led efforts to negotiate the Addis Ababa Action Agenda, in which 193 countries committed to the financing necessary to achieve the Sustainable Development Goals.
Dr Tedros served as Ethiopia’s Minister of Health from 2005–2012, where he led a comprehensive reform of the country’s health system. All roads lead to universal health coverage for Dr Tedros, and he has demonstrated what it takes to expand access to health care with limited resources. The transformation he led as Ethiopia’s Minister of Health improved access to health care for millions of people. Under his leadership Ethiopia invested in critical health infrastructure, expanded its health workforce, and developed innovative health financing mechanisms.
Beyond Ethiopia, Dr Tedros’ global leadership on malaria, HIV/AIDS, and maternal and child health has been immensely impactful. He was elected as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria Board in 2009, and previously served as Chair of the Roll Back Malaria Partnership Board, and Co-chair of the Partnership for Maternal, Newborn and Child Health Board. Born in the city of Asmara, Eritrea, Dr Tedros holds a Doctorate of Philosophy (PhD) in Community Health from the University of Nottingham and a Master of Science (MSc) in Immunology of Infectious Diseases from the University of London. Dr Tedros is globally recognised as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics.
Throughout his career Dr Tedros has published numerous articles in prominent scientific journals, and received awards and recognition from across the globe. He received the Decoration of the Order of Serbian Flag in 2016, and was awarded the Jimmy and Rosalynn Carter Humanitarian Award in recognition of his contributions to the field of public health in 2011.
Dr. David Dodd GeoVax
CEOGeoVaxUSA
Dr. Alexandre Le Vert OSIVAX
CEOOSIVAXFrance
Dr. Jakob Cramer CEPI
Head of Clinical DevelopmentCEPIUK
Jeffrey Wolf Heat Biologics
CEOHeat BiologicsUSA
Amgad Gamil Pfizer
Senior Director, Medical & Scientific Affairs Emerging MarketsPfizerDubai
Dr. Dina Berdieva Bill & Melinda Gates Medical Research Institute
Project Management & Clinical Operations LeaderBill & Melinda Gates Medical Research InstituteUSA
Frederic Ors IMV Inc
CEOIMV IncCanada
Jorge Fragoso Sanofi Pasteur
Vaccines Global Project HeadSanofi PasteurMexico
ShouBai Chou CanSino Biologics
COOCanSino BiologicsChina
Nikolai Petrovsky Vaxine Pty Ltd
Chairman and Research DirectorVaxine Pty LtdAustralia
Dr. Ashish Sahai Serum Institute of India
Director – Viral VaccinesSerum Institute of IndiaIndia
Dr. Ingrid Kromann CEPI
Head of ManufacturingCEPIUK
Kevin Wang Beijing CC-Pharming
CEOBeijing CC-PharmingChina
Dr. Ajoy Chakrabati Bill & Melinda Gates Foundation
Portfolio and Platform LeaderBill & Melinda Gates FoundationUSA
Dr. Raghavan Varadarajan Indian Institute of Science
CEOIndian Institute of ScienceIndia
Dr. Alexandre Le Vert OSIVAX
CEOOSIVAXFrance
Dr. Tzyy-Choou Wu Johns Hopkins University School of Medicine
Professor - Oncology & Obstetrics and Gynecology & Director of GynecologicJohns Hopkins University School of MedicineUSA
Prof Maria Elena Bottazzi Baylor College of Medicine
Associate DeanBaylor College of MedicineUSA
Dr. Lily Wu Papivax
CEO and Co- FounderPapivaxTaiwan
Dr. Jean-Louis Excler International Vaccine Institute
Program Director - New InitiativesInternational Vaccine InstituteKorea
Dr. Shweta Chatrath IAVI
Manager R&D ProgramsIAVIIndia
Dr. Ramesh Matur Biological E Ltd
SVP & Head R&D – VaccinesBiological E LtdIndia
Pierre A. Morgon Eurocine Vaccines, NED, Vaccitech, NED, Univercells
CEO | Chairman | Non Executive Director | Mentor | AdvisorEurocine Vaccines, NED, Vaccitech, NED, Univercells
Sanjay Singh Gennova Biopharmaceuticals Ltd, India
Chief Executive OfficerGennova Biopharmaceuticals Ltd, India
Dr. Asel Sartbaeva University of Bath
LecturerUniversity of BathUnited Kingdom
Prof Vasan Vasan
Dangerous Pathogen Team LeaderAustralia
Dr. Ashraf Mohammadi Razi Vaccine & Serum Research Institute
Head of Human Viral VaccineRazi Vaccine & Serum Research InstituteIran
Dr. Arindam Ray Bill & Melinda Gates Foundation
India Country Lead - New Vaccines & Immunizations SystemsBill & Melinda Gates FoundationIndia
Dr. Raj Shankar Ghosh Bill and Melinda Gates Foundation
Deputy Director, Vaccine DeliveryBill and Melinda Gates Foundation IndiaRaj Shankar is a physician with 25 years of engagement in public health program policy, planning, implementation. Raj has worked in a large variety of organizations that ranged from small field level non-governmental organizations; State Health services; World Health Organization; international developmental partners such as PATH and Institute for OneWorld Health; and donor organization Bill & Melinda Gates Foundation. Some of the key positions that he held in his career are Block Medical Officer In-Charge, West Bengal Health Services; Surveillance Medical Officer; National Polio Surveillance Project (NPSP) of WHO - India; Regional Coordinator, South East Region, NPSP, WHO-India; Technical Director, Immunization, PATH-India; Director, Multi Country Japanese Encephalitis Project, South East Asia-Western Pacific Region, PATH; Regional Director, South Asia, Institute for OneWorld Health and Deputy Director, Vaccine Delivery and Infectious Diseases, Bill & Melinda Gates Foundation. Raj has led a team of clinical researchers to develop drugs for neglected diseases like Visceral Leishmaniasis in South Asia; has influenced policy decisions in new vaccine introduction in multiple countries in South Asia and spearheaded public health program planning and implementation in India and Nepal. His current focus is primarily in advocacy for evidence based policies and capacity building of public health institutions in India.Raj Shankar has multiple publications and has authored chapters on vaccines in books for pediatricians. He was awarded the prestigious Fellowship of Indian Public Health Association in 2014.
Past Sponsors & Exhibitors
Showcase Your Solutions To Asia's Top Vaccines Executives
Vaccine World Asia Congress 2021 will provide you with the opportunity to educate the market about your offerings and position yourselves as leaders in your field alongside key industry figures! This is an EXCEPTIONAL opportunity to position your brand and business before the Asia’s top vaccine executives. Make sure you get access to the region’s hottest life science sub-sector.
Market Intelligence
LATEST! eBook: Therapeutics & Prophylactic Vaccine Pipelines (Asia)
Exclusive! Challenges in Vaccine Development - A Regulatory Perspective
In this eBook, IMAPAC has brought you a survey report, highlighting the industry’s thoughts on some of the challenges and thereby, opportunities for future improvement and advancement in the various areas of the vaccine development and manufacturing chain.
Join Vaccine World Asia Congress 2021!
Registration & Media
Kashmiira Nayar
Marketing Manager - Vaccines World Asia 2020
Email: kashmiira.nayar@imapac.com
Sponsorship & Exhibition
Charmaine Poh
Business Development Manager - Vaccines World Asia 2020
Email: charmaine.poh@imapac.com
English 
简体中文 
日本語 
한국어 
繁體中文